論文

査読有り
2017年10月

Alternative to Rituximab Therapy for a Patient with Ankylosing Spondylitis Who Was Unable to Continue Anti-TNF Therapy

ACTA MEDICA OKAYAMA
  • Eri Katsuyama
  • ,
  • Hiroshi Wakabayashi
  • ,
  • Ken-ei Sada
  • ,
  • Sumie Hiramatsu
  • ,
  • Yoshia Miyawaki
  • ,
  • Michiko Morishita
  • ,
  • Keiji Ohashi
  • ,
  • Haruki Watanabe
  • ,
  • Takayuki Katsuyama
  • ,
  • Sonia Zeggar
  • ,
  • Mariko Narazaki
  • ,
  • Noriko Tatebe
  • ,
  • Katsue S. Watanabe
  • ,
  • Tomoko Kawabata
  • ,
  • Jun Wada

71
5
開始ページ
445
終了ページ
448
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.18926/AMO/55444
出版者・発行元
OKAYAMA UNIV MED SCHOOL

We herein present a case of a 38-year-old man who had bamboo spine and severe sacroiliitis and who was diagnosed with ankylosing spondylitis (AS). Infliximab (IFX) markedly improved the axial symptom but was discontinued due to the side effect of peripheral neuropathy. Switching from IFX to etanercept worsened the side effect. Rituximab (RTX) administration elicited a good response without side effects. RTX might be a suitable option for AS therapy when TNF inhibitors are difficult to use.

Web of Science ® 被引用回数 : 1

リンク情報
DOI
https://doi.org/10.18926/AMO/55444
Web of Science
https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000418747700012&DestApp=WOS_CPL
URL
https://www.ncbi.nlm.nih.gov/pubmed/29042704
URL
http://orcid.org/0000-0003-1468-5170
ID情報
  • DOI : 10.18926/AMO/55444
  • ISSN : 0386-300X
  • ORCIDのPut Code : 43365852
  • Web of Science ID : WOS:000418747700012

エクスポート
BibTeX RIS